Triangle Securities Wealth Management Decreases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Triangle Securities Wealth Management trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.4% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,196 shares of the financial services provider’s stock after selling 148 shares during the quarter. Triangle Securities Wealth Management’s holdings in iShares Biotechnology ETF were worth $423,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Ameritas Advisory Services LLC lifted its position in shares of iShares Biotechnology ETF by 9.4% during the fourth quarter. Ameritas Advisory Services LLC now owns 29,094 shares of the financial services provider’s stock valued at $3,847,000 after buying an additional 2,508 shares during the last quarter. Mirador Capital Partners LP increased its holdings in shares of iShares Biotechnology ETF by 0.6% during the fourth quarter. Mirador Capital Partners LP now owns 29,698 shares of the financial services provider’s stock valued at $3,926,000 after acquiring an additional 187 shares in the last quarter. Clarus Wealth Advisors increased its holdings in shares of iShares Biotechnology ETF by 1.4% during the fourth quarter. Clarus Wealth Advisors now owns 11,383 shares of the financial services provider’s stock valued at $1,526,000 after acquiring an additional 161 shares in the last quarter. Pines Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $317,000. Finally, Sharper & Granite LLC increased its holdings in shares of iShares Biotechnology ETF by 2.8% during the fourth quarter. Sharper & Granite LLC now owns 6,250 shares of the financial services provider’s stock valued at $826,000 after acquiring an additional 170 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

IBB opened at $132.65 on Monday. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The firm’s 50-day moving average price is $136.62 and its 200-day moving average price is $141.86.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.